Compounds > 1-methyl-3-isobutylxanthine
Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and African Lymphoma

1-methyl-3-isobutylxanthine has been researched along with African Lymphoma in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hoak, JC1
Parks, WM1
Fry, GL1
Brotherton, AA1
Czervionke, RL1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and African Lymphoma

ArticleYear
Role of the vascular endothelium.
    Progress in clinical and biological research, 1982, Volume: 89

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Aspirin; Burkitt Lymphoma; Cattle; Cell Line; Cells, Cultured;

1982